Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis

Ranzani OT, Bassi GL, Torres A
Dec 1, 2016
Publication
Intensive Care Med. 42(12):2119-2120. 10.1007/s00134-016-4469-2
Full text
Read the paper (DOI)
Metrics (OpenAlex)
Citations: 4 · FWCI: 0.91 · Access: closed
Ranzani OT
Ranzani OT
Group Leader

I am a scientist, born in 🇧🇷.